EMA is the agency responsible for regulating medicines in EU. EMA is counterpart of FDA. Till recently EMA was not forth coming in sharing drug-trail data with independent researches like Cochrane. The reason given by EMA were:

- 'these documents have commercial data'
- 'these documents have patient personal data'
- 'these documents have data about the design of clinical trail'
- 'documents  were shredded because it passed legal hold period'.
-'you can use the data for analysis but should not publish the results'

Going by these excuses EMA is representing drug makers, not the people or tax payers.

Independent researcher's struggle with EMA

Now EMA has made all drug-trail data available for scrutiny.